MyFinsight
Home
Blog
About
Back
Income Statement
Aspire Biopharma Holdings, Inc. (ASBPW)
Aspire Biopharma Holdings, Inc. (ASBPW)
source: myfinsight.com
Net loss
-$1,268,142
(35.99%↑ Y/Y)
Loss (gain) on
extinguishment of debt
$1,353,679
(471.78%↑ Y/Y)
Interest income
$56,676
Loss before
provision for income taxes
-$1,268,142
Total other expense,
net
$1,410,080
(219.36%↑ Y/Y)
Change in fair value of
derivative liabilities and...
-$275
(99.90%↑ Y/Y)
Loss from operations
-$2,678,222
Total operating
expenses
$2,648,136
(231.06%↑ Y/Y)
Gross margin
-$30,086
Net revenue
$63,104
Sales and marketing
$1,215,025
(2267.96%↑ Y/Y)
General and
administrative (including...
$970,211
(145.19%↑ Y/Y)
Research and development
$233,482
(-33.84%↓ Y/Y)
Merger and acquisition
expenses
$229,418
Cost of revenue
$50,818
Inventory write off
$42,372
Back